These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 18378942
21. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania. Şuteu O, Blaga ML, Nygård M, Leinonen MK, Nicula F, Păiş R, Coza D, Cadariu PA, Melnic A, Andreassen T, Hashim D, Weiderpass E. Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568 [Abstract] [Full Text] [Related]
22. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA. J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908 [Abstract] [Full Text] [Related]
23. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ. Int J Cancer; 1996 Dec 11; 68(6):766-9. PubMed ID: 8980181 [Abstract] [Full Text] [Related]
24. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Petignat P, Faltin D, Goffin F, Billieux MH, Stucki D, Sporri S, Vassilakos P. Cancer; 2005 Jun 25; 105(3):126-32. PubMed ID: 15822123 [Abstract] [Full Text] [Related]
25. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania]. Feticu L, Bocşan IS, Bondor Cl, Boboş C. Rev Med Chir Soc Med Nat Iasi; 2012 Jun 25; 116(2):567-74. PubMed ID: 23077955 [Abstract] [Full Text] [Related]
26. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3. Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Arch Pathol Lab Med; 2013 Jul 25; 137(7):942-7. PubMed ID: 23050808 [Abstract] [Full Text] [Related]
27. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016. Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK. J Gynecol Oncol; 2018 Jan 25; 29(1):e14. PubMed ID: 29185272 [Abstract] [Full Text] [Related]
28. Less frequent Pap smears for low-risk women? Sanders FN. S Afr Med J; 2004 Jun 25; 94(6):435-6. PubMed ID: 15250453 [No Abstract] [Full Text] [Related]
29. Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China. Yuan X, Yang Y, Gu D, Liu H, Yang H, Wang M. Arch Gynecol Obstet; 2011 Jun 25; 283(6):1385-9. PubMed ID: 20628750 [Abstract] [Full Text] [Related]
30. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. Widdice LE, Moscicki AB. J Adolesc Health; 2008 Oct 25; 43(4 Suppl):S41-51. PubMed ID: 18809144 [Abstract] [Full Text] [Related]
32. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. J Natl Cancer Inst; 2004 Feb 18; 96(4):280-93. PubMed ID: 14970277 [Abstract] [Full Text] [Related]
34. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing? Coorevits L, Traen A, Bingé L, Van Dorpe J, Praet M, Boelens J, Padalko E. J Gynecol Oncol; 2018 Jan 18; 29(1):e8. PubMed ID: 29185266 [Abstract] [Full Text] [Related]
35. A comparison of cervical and vaginal human papillomavirus. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD. Sex Transm Dis; 2007 Nov 18; 34(11):849-55. PubMed ID: 17621246 [Abstract] [Full Text] [Related]
37. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. J Virol Methods; 2008 Jan 18; 147(1):10-7. PubMed ID: 17854914 [Abstract] [Full Text] [Related]